147 related articles for article (PubMed ID: 9027610)
1. Inherited and acquired risk factors in colonic neoplasia and modulation by chemopreventive interventions.
Lipkin M; Yang K; Edelmann W; Newmark H; Fan KH; Risio M; Kucherlapati R
J Cell Biochem Suppl; 1996; 25():136-41. PubMed ID: 9027610
[TBL] [Abstract][Full Text] [Related]
2. New rodent models for studies of chemopreventive agents.
Lipkin M
J Cell Biochem Suppl; 1997; 28-29():144-7. PubMed ID: 9589360
[TBL] [Abstract][Full Text] [Related]
3. Calcium and the prevention of colon cancer.
Lipkin M; Newmark H
J Cell Biochem Suppl; 1995; 22():65-73. PubMed ID: 8538212
[TBL] [Abstract][Full Text] [Related]
4. Strategies for intervention with chemopreventive agents.
Lipkin M
Int J Cancer; 1996 Feb; 69(1):64-7. PubMed ID: 8600066
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon.
Yang K; Lamprecht SA; Liu Y; Shinozaki H; Fan K; Leung D; Newmark H; Steele VE; Kelloff GJ; Lipkin M
Carcinogenesis; 2000 Sep; 21(9):1655-60. PubMed ID: 10964096
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of colon cancer by Korean food plant components.
Kim DJ; Shin DH; Ahn B; Kang JS; Nam KT; Park CB; Kim CK; Hong JT; Kim YB; Yun YW; Jang DD; Yang KH
Mutat Res; 2003; 523-524():99-107. PubMed ID: 12628507
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
8. Summary of recommendations for colonic biomarker studies of candidate chemopreventive compounds in phase II clinical trials.
Lipkin M
J Cell Biochem Suppl; 1994; 19():94-8. PubMed ID: 7823612
[TBL] [Abstract][Full Text] [Related]
9. Intermediate biomarkers of increased risk for colorectal cancer: comparison of different methods of analysis and modifications by chemopreventive interventions.
Scalmati A; Lipkin M
J Cell Biochem Suppl; 1992; 16G():65-71. PubMed ID: 1469906
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate.
Rao CV; Desai D; Rivenson A; Simi B; Amin S; Reddy BS
Cancer Res; 1995 Jun; 55(11):2310-5. PubMed ID: 7757981
[TBL] [Abstract][Full Text] [Related]
11. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms in the chemoprevention of colon cancer: modulation of protein kinase C, tyrosine protein kinase and diacylglycerol kinase activities by 1,4-phenylenebis-(methylene)selenocyanate and impact of low-fat diet.
Rao CV; Simi B; Hirose Y; Upadhyaya P; El-Bayoumy K; Reddy BS
Int J Oncol; 2000 Mar; 16(3):519-27. PubMed ID: 10675484
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive effects of orange peel extract (OPE). I: OPE inhibits intestinal tumor growth in ApcMin/+ mice.
Fan K; Kurihara N; Abe S; Ho CT; Ghai G; Yang K
J Med Food; 2007 Mar; 10(1):11-7. PubMed ID: 17472461
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin, lectin, and acidic mucin modulation in differentiating colonic epithelial cells of mice after feeding Western-style diets.
Yang K; Fan K; Newmark H; Leung D; Lipkin M; Steele VE; Kelloff GJ
Cancer Res; 1996 Oct; 56(20):4644-8. PubMed ID: 8840978
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal cancer: pathogenesis, risk factors and the development of intermediate biomarkers for chemoprevention studies.
Lipkin M
J Cell Biochem Suppl; 1992; 16G():1-13. PubMed ID: 1469890
[TBL] [Abstract][Full Text] [Related]
16. Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.
Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Steele VE; Lubet RA; Sigman CC
J Cell Biochem Suppl; 1995; 23():1-9. PubMed ID: 8747372
[TBL] [Abstract][Full Text] [Related]
17. Cohorts with familial disposition for colon cancers in chemoprevention trials.
Burt RW
J Cell Biochem Suppl; 1996; 25():131-5. PubMed ID: 9027609
[TBL] [Abstract][Full Text] [Related]
18. Loss of free fatty acid receptor 2 enhances colonic adenoma development and reduces the chemopreventive effects of black raspberries in ApcMin/+ mice.
Pan P; W Skaer C; Wang HT; Oshima K; Huang YW; Yu J; Zhang J; M Yearsley M; A Agle K; R Drobyski W; Chen X; Wang LS
Carcinogenesis; 2017 Jan; 38(1):86-93. PubMed ID: 27866157
[TBL] [Abstract][Full Text] [Related]
19. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs.
Pereira MA
Adv Exp Med Biol; 1999; 470():55-63. PubMed ID: 10709674
[TBL] [Abstract][Full Text] [Related]
20. Early development of cancer chemoprevention clinical trials: studies of dietary calcium as a chemopreventive agent for human subjects.
Lipkin M
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S65-70. PubMed ID: 12570337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
